Inhouse product
Linita is
indicated in the treatment of type 2 diabetes mellitus to improve glycaemic control
in adults.
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Linagliptin is
indicated to improve glycemic control in patients with type 2 diabetes
mellitus. Linagliptin is an inhibitor of DPP-4 (dipeptidyl peptidase-4), an
enzyme that degrades the incretin hormones GLP-1 (glucagon like peptide-1) and
GIP (glucose dependent insulinotropic polypeptide). Thus, Linagliptin increases
the concentrations of active incretin hormones, stimulating the release of
insulin from pancreatic beta (β) cells in a glucose-dependent manner and
decreasing the secretion of glucagon from pancreatic alpha (α) cells in the
circulation.
Linagliptin 5
mg once daily. If added to metformin, the dose of metformin should be
maintained and linagliptin administered concomitantly. When used in combination
with a sulfonylurea, a lower dose of the sulphonylurea may be considered to
reduce the risk of hypoglycaemia.
Patients with renal impairment: No dose adjustment required. Linagliptin can be
taken with or without a meal at any time of the day.
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Linita is a
weak competitive and a weak to moderate mechanism-based inhibitor of CYP
isozyme CYP3A4, but does not inhibit other CYP isozymes. The risk for
clinically meaningful interactions by other medicinal products on Linita is low
and in clinical studies Linita had no clinically relevant effect on the
pharmacokinetics of metformin, glyburide, simvastatin, warfarin, digoxin or
oral contraceptives.
Hypersensitivity
to the active substance or to any of the excipients.
There may be
hypoglycaemia, nasopharyngitis, cough and pancreatitis in combination with
metformin and sulfonylurea.
Pregnancy
category B. There are no adequate and well controlled studies in pregnant
women. So, Linagliptin tablets should be used during pregnancy only if clearly
needed. It is not known whether Linagliptin passes into breast milk or not.
Hypersensitivity
to the active substance or to any of the excipients.
Dipeptidyl
Peptidase-4 (DPP-4) inhibitor
Keep in a dry
place away from light and heat. Keep out of the reach of children.
|
Molecular Formula : |
C25H28N8O2 |
|
Chemical Structure : |
|
Linita 5 mg
Tablet is an inhibitor of DPP-4 enzyme.
Linita 5 mg
Tablet is used for the treatment of type 2 diabetes mellitus to improve
glycaemic control in adults.
Linita 5 mg
Tablet is to be taken till the time you see an improvement in your health
conditions.
Linita 5 mg
Tablet should be taken in the dosage as prescribed by the doctor.
Linita 5 mg
Tablet should be taken after food in a prescribed dosage.
Linita 5 mg
Tablet should be kept in a cool dry place and in its original packaging. Make
sure this medication remains unreachable to children and pets.
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Login Or Registerto submit your questions to seller
No none asked to seller yet